Zobrazeno 211 - 215
of 215
pro vyhledávání: '"Alessandro M. Gianni"'
Autor:
Carmelo Carlo-Stella, Simonetta Viviani, Lucia Farina, Roberto Sorasio, Anna Dodero, Andrea Anichini, Anna Guidetti, Paolo Corradini, Alessandro M. Gianni, Silvia L. Locatelli, Massimo Di Nicola, Pietro Bulian, Domenico Russo
Publikováno v:
Publons
Abstract 3705 INTRODUCTION: Identification of predictive biomarkers of response to molecularly targeted therapy represents a challenging issue. Therefore, we conducted a pharmacodynamic study evaluating phosphorylation levels of ERK (pERK) and AKT (p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ea68304cefa46ff985ecb422e114b9f
https://publons.com/publon/28924515/
https://publons.com/publon/28924515/
Autor:
Massimo Di Nicola, Chiara Forni, Paola Matteucci, Claudia Erminero, Carmelo Carlo-Stella, Anna Guidetti, Antonella De Pascale, Michele Magni, Alessandro M. Gianni, Carlo Chiesa, Marco Maccauro, Angela Coliva, Emilio Bombardieri, Ettore Seregni, Liliana Devizzi
Publikováno v:
Publons
Background : High dose chemotherapy has an established, albeit limited role, in the management of non-Hodgkin lymphoma (NHL). In fact, because of its toxicity, in particular mucositis, neutropenia and thrombocytopenia, myeloablative regimens with aut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b67c223dc98b89c0446d035bd5cb6bb1
https://publons.com/publon/20429438/
https://publons.com/publon/20429438/
Publikováno v:
Scopus-Elsevier
The identification of genes inducing resistance to anticancer chemotherapeutic agents and their introduction into hematopoietic cells represents a promising approach to overcome bone marrow toxicity, the limiting factor for most high-dose chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b505e489e4c16c0c7fa87e3c012ccd8b
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030024868&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0030024868&partnerID=MN8TOARS
Autor:
Marek Trnĕný, Gregor Verhoef, Martin JS Dyer, Dina Ben Yehuda, Caterina Patti, Miguel Canales, Andrés Lopez, Farrukh T Awan, Paul G Montgomery, Andrea Janikova, Anna M Barbui, Kazimierz Sulek, Maria J Terol, John Radford, Anna Guidetti, Massimo Di Nicola, Laure Siraudin, Laurence Hatteville, Sandrine Schwab, Corina Oprea, Alessandro M Gianni
Publikováno v:
Haematologica, Vol 103, Iss 8 (2018)
This phase II, single-arm, multicenter study examined the efficacy and safety of coltuximab ravtansine (an anti-CD19 antibody drug conjugate) in 61 patients with histologically documented (de novo or transformed) relapsed or refractory diffuse large
Externí odkaz:
https://doaj.org/article/285c418d9cd14133b9f44dd7209b4fad
Autor:
Carmelo Carlo-Stella, Silvia L Locatelli, Arianna Giacomini, Loredana Cleris, Elena Saba, Marco Righi, Anna Guidetti, Alessandro M Gianni
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61603 (2013)
The anti-lymphoma activity and mechanism(s) of action of the multikinase inhibitor sorafenib were investigated using a panel of lymphoma cell lines, including SU-DHL-4V, Granta-519, HD-MyZ, and KMS-11 cell lines. In vitro, sorafenib significantly dec
Externí odkaz:
https://doaj.org/article/d9ef758d4d284af684f9f747be1a2728